Related Experiment Video

Updated: Jun 13, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.8K

Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMD

Alex Philippidis1

  • 1Genetic Engineering & Biotechnology News Mary Ann Liebert, Inc., publishers 140 Huguenot Street New Rochelle, NY 10801.

Human Gene Therapy
|September 16, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.1K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

18.7K

Related Concept Videos